Back to results
US 8,575,105 B2Granted
Use of the engrailed homeodomain protein as anxiolytic
AssigneeCentre National De La Recherche Scientifique
InventorsAlain Prochiantz, Michel Volovitch
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an Engrailed transcription factor for producing a medicament for anxiolytic purposes.
Claims4
A method of inducing an anxiolytic effect in a subject in need thereof, comprising administering an Engrailed protein 2 to the subject in an amount sufficient to induce the anxiolytic effect in the subject.
Dependencies are inferred from the claim text.